Skip to main content
. Author manuscript; available in PMC: 2020 Jun 4.
Published in final edited form as: Leuk Lymphoma. 2020 Feb 24;61(6):1395–1405. doi: 10.1080/10428194.2020.1723016

Figure 3.

Figure 3.

(A) Overall survival curves for cases of AML with RUNX1mut with or without concurrent DNMT3A mutation. (B) Overall survival curves for cases of AML-MRC with concurrent RUNX1/DNMT3A mutation compared to cases with RUNX1 mutation alone.